• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 99-113 of 513 results

1011 Exhibit: Ex 1011 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Judgment an...

Document IPR2017-01103, No. 1011-10 Exhibit - Ex 1011 Elan Pharma Intl Ltd v Abraxis BioScience, Inc, Judgment and Verdict Form, No 06 438 GMS, Dkt 614 D Del June 16, 2008 (P.T.A.B. Apr. 4, 2017...

cite Cite Document
Analyze

1023 Exhibit: Ex 1023 US Application No 11553,339, Declaration of Neil P Desai Pu...

Document IPR2017-01103, No. 1023-22 Exhibit - Ex 1023 US Application No 11553,339, Declaration of Neil P Desai Pursuant to 37 CFR 1132 dated Apr 14, 2010 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1004 Exhibit: Ex 1004 Kadima et al, WO 2000006152, published Feb 10, 2000 Kad...

Document IPR2017-01103, No. 1004-3 Exhibit - Ex 1004 Kadima et al, WO 2000006152, published Feb 10, 2000 Kadima (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1015 Exhibit: Ex 1015 Patient Information Leaflet, ABRAXANE for Injectable Suspe...

Document IPR2017-01103, No. 1015-14 Exhibit - Ex 1015 Patient Information Leaflet, ABRAXANE for Injectable Suspension paclitaxel protein bound particles for injectable suspension albumin bound rev...

cite Cite Document
Analyze

1017 Exhibit: Ex 1017 Damascelli, B et al Intraarterial chemotherapy with polyoxye...

Document IPR2017-01103, No. 1017-16 Exhibit - Ex 1017 Damascelli, B et al Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles ABI 007, Can...

cite Cite Document
Analyze

1016 Exhibit: Ex 1016 Administrative Documents, New Drug Application No 21 660

Document IPR2017-01103, No. 1016-15 Exhibit - Ex 1016 Administrative Documents, New Drug Application No 21 660 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1024 Exhibit: Ex 1024 US Application No 11553,339, Notice of Allowance and Fees...

Document IPR2017-01103, No. 1024-23 Exhibit - Ex 1024 US Application No 11553,339, Notice of Allowance and Fees Due mailed June 1, 2010 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

1005 Exhibit: Ex 1005 Liversidge et al, US Patent No 5,399,363

Document IPR2017-01103, No. 1005-4 Exhibit - Ex 1005 Liversidge et al, US Patent No 5,399,363 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

Letter

Document ABRAXANE, 021660, Letter (Orange Book Dec. 6, 2019)

cite Cite Document
Analyze

Label

Document ABRAXANE, 021660, Label (Orange Book Dec. 6, 2019)

cite Cite Document
Analyze

COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGEN...

Docket 12/758,413, U.S. Patent Application (April 12, 2010)

cite Cite Docket
Analyze

Letter

Document ABRAXANE, 021660, Letter (Orange Book Aug. 16, 2018)

cite Cite Document
Analyze

Label

Document ABRAXANE, 021660, Label (Orange Book Aug. 16, 2018)

cite Cite Document
Analyze

1003 Exhibit: Ex 1003 Desai et al, US Patent No 5,439,686

Document IPR2017-01103, No. 1003-2 Exhibit - Ex 1003 Desai et al, US Patent No 5,439,686 (P.T.A.B. Apr. 4, 2017)

cite Cite Document
Analyze

2052 Exhibit: Exhibit 2052

Document IPR2017-01103, No. 2052-76 Exhibit - Exhibit 2052 (P.T.A.B. Jul. 12, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 7 8 9 10 11 ... >>